Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ContourGlobal PLC Director's Dealing 2020

Apr 7, 2020

9182_dirs_2020-04-07_9828596e-91ad-46c3-b491-1309548bd181.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

RNS Number : 1242J

ContourGlobal PLC

07 April 2020

ContourGlobal plc

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility

1.

Details of PDMR

a)

Name

Joseph C. Brandt

2.

Details of PDMR

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ContourGlobal plc

b)

LEI

5493002I3A4J5TFOR115

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

c)

Description of the financial instrument

Ordinary shares of £0.01 each

ISIN: GB00BF448H58

d)

Nature of the transaction

Release of shares under the Company's Deferred Bonus Scheme.

e)

Price(s) and volume(s)

Price(s) Volume(s)
61,847

f)

Aggregated information

-Aggregated volume

-Aggregated price

61,847

N/A

g)

Date of the transaction

7 April 2020

h)

Place of the transaction

London Stock Exchange, Main Market - XLON

Contact:

Penny Thomas

Company Secretary

ContourGlobal plc

+44 (0) 203 626 9033

116 Park Street, Park House, 7th Floor, London W1K 6SS

Registered in England and Wales, No. 10982736

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHSSAFMWESSEEL